GL1X · GenesisL1 explorer

MolNFT v1 · #73351 · protein

Structural analysis of pneumocystis carinii and human DHFR complexes with NADPH and a series of five 5-(omega-CARBOXY(ALKYLOXY(PYRIDO[2,3- D]PYRIMIDINE derivatives

3NZD · Dihydrofolate reductase: “Structural analysis of pneumocystis carinii and human DHFR complexes with NADPH and a series of five…”. X-ray diffraction, 2 ligands (D2Q, NDP), 1 pocket (best druggability 0.74). MolNFT v1 #73351 on…

PDB
3NZD
Type
protein
Length
186 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydrofolate reductase
EC
1.5.1.3
UniProt
P00374
Ligands
D2Q, NDP
Pockets
1 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 20% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydrofolate reductase (EC 1.5.1.3)protein18620% helix, 33% strandP00374

Ligands and binding sites

  • D2Q · ethyl 5-{2-[(2,4-diamino-5-methylpyrido[2,3-d]pyrimidin-6-yl)methyl]-4-methoxyphenoxy}pentanoate · ligand · chains A
  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14010.740.8446D2Q, NDP

Compared structures

  • 3NZD · Structural Analysis of Pneumocystis carinii and Human DHFR Complexes with NADPH and a… · the same entry in another collection · chain A against A, TM-score 1.00
  • P00374 · AlphaFold monomer V2.0 prediction for dihydrofolate reductase (P00374) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.